Free Trial

NewGenIvf Group (NIVF) 10K Form and Latest SEC Filings 2026

NewGenIvf Group logo
$1.46 -0.23 (-13.61%)
Closing price 04:00 PM Eastern
Extended Trading
$1.42 -0.04 (-3.08%)
As of 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Latest NewGenIvf Group SEC Filings & Recent Activity

NewGenIvf Group (NASDAQ:NIVF) has submitted 82+ documents to the U.S. Securities and Exchange Commission (SEC) since 2023. For investors, these filings are the primary source of verified financial data — covering everything from annual revenue and debt levels in the 10-K, to material business events in 8-K current reports, to insider buying and selling activity in Form 4 disclosures. The most recent filing was a Form 20-F submitted on March 31, 2026.

20-F
NewGenIvf Group Files Annual Report on Mar. 31, 2026

The 20-F contains NewGenIvf Group's audited financial statements, revenue, earnings, and risk factors for the prior fiscal year.

View earnings history

NewGenIvf Group SEC Filing History

Browse NewGenIvf Group's complete SEC filing history using the filters below. Filter by form type - 10-K, 10-Q, 8-K, Form 4, and more - or set a custom date range to find a filing.

DateFilerForm TypeView
03/31/2026 4:29 PM
NewGenIvf Group (1981662) Filer
Form 20-F
Registration statement / Annual report / Transition report  
03/31/2026 5:35 AM
NewGenIvf Group (1981662) Issuer
Siu Wing Fung Alfred (2009969) Reporting
Form 3
Initial statement of beneficial ownership of securities  
03/27/2026 5:27 AM
NewGenIvf Group (1981662) Issuer
Tam Chun Wa (2124603) Reporting
Form 3
Initial statement of beneficial ownership of securities  
03/27/2026 5:29 AM
Ching Chan Florianna Ann Chi Wan (2123676) Reporting
NewGenIvf Group (1981662) Issuer
Form 3
Initial statement of beneficial ownership of securities  
03/27/2026 5:31 AM
Fong Hei Yue Tina (2009968) Reporting
NewGenIvf Group (1981662) Issuer
Form 3
Initial statement of beneficial ownership of securities  
03/24/2026 7:00 AM
Au Hok Man Jefferson (2123652) Reporting
NewGenIvf Group (1981662) Issuer
Form 3
Initial statement of beneficial ownership of securities  
03/23/2026 6:00 AM
Chan Chung Ho (2121106) Reporting
NewGenIvf Group (1981662) Issuer
Form 3
Initial statement of beneficial ownership of securities  
03/15/2026 11:15 PM
NewGenIvf Group (1981662) Filer
Form EFFECT
03/13/2026 7:01 AM
NewGenIvf Group (1981662) Filer
Form 424B3
03/11/2026 7:03 AM
NewGenIvf Group (1981662) Filer
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/02/2026 4:30 PM
NewGenIvf Group (1981662) Filer
Form F-1
Registration statement for securities of certain foreign private issuers  
01/20/2026 7:07 AM
NewGenIvf Group (1981662) Filer
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/02/2025 7:01 AM
NewGenIvf Group (1981662) Filer
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/10/2025 7:30 AM
NewGenIvf Group (1981662) Filer
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/05/2025 9:24 AM
NewGenIvf Group (1981662) Filer
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/31/2025 9:49 AM
NewGenIvf Group (1981662) Filer
Form 424B3
10/10/2025 3:19 PM
NewGenIvf Group (1981662) Filer
Form F-1/A
10/09/2025 6:42 AM
NewGenIvf Group (1981662) Filer
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/18/2025 1:32 PM
NewGenIvf Group (1981662) Filer
Form F-1
Registration statement for securities of certain foreign private issuers  
09/16/2025 9:37 AM
NewGenIvf Group (1981662) Filer
Form F-1
Registration statement for securities of certain foreign private issuers  
07/28/2025 7:48 AM
NewGenIvf Group (1981662) Filer
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/21/2025 6:00 AM
NewGenIvf Group (1981662) Filer
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/01/2025 6:00 AM
NewGenIvf Group (1981662) Filer
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/20/2025 3:30 PM
NewGenIvf Group (1981662) Filer
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/17/2025 7:00 AM
NewGenIvf Group (1981662) Filer
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/04/2025 11:45 AM
NewGenIvf Group (1981662) Filer
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/03/2025 11:15 PM
NewGenIvf Group (1981662) Filer
Form EFFECT
06/03/2025 3:30 PM
NewGenIvf Group (1981662) Filer
Form 424B3
06/02/2025 7:30 AM
NewGenIvf Group (1981662) Filer
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/29/2025 8:43 AM
NewGenIvf Group (1981662) Filer
Form F-1/A
05/20/2025 10:47 AM
NewGenIvf Group (1981662) Filer
Form F-1/A
05/15/2025 11:49 AM
NewGenIvf Group (1981662) Filer
Form 20-F/A
(Data available from 1/1/2016 forward)

NewGenIvf Group SEC Filings - Frequently Asked Questions

NewGenIvf Group (NIVF) has submitted 82+ filings to the SEC since 2023. You can browse the complete history or filter by form type using the tools above.

NewGenIvf Group's fiscal year ends on December 31. The company typically files its 10-K annual report by the end of February, covering the prior fiscal year's financial results.

The most recent filing was a Form 20-F submitted on March 31, 2026. View the full filing using the link above.

SEC Filing Types: 10-K, 10-Q, 8-K and More

SEC filings are legally required disclosures that public companies submit to the U.S. Securities and Exchange Commission. Unlike press releases or earnings call transcripts, these documents are filed under legal obligation — meaning the financial data they contain is audited, standardized, and subject to penalties if materially false. For investors, that makes SEC filings the most reliable primary source available for evaluating a company's true financial position.

Yes. All SEC filings are publicly available through the SEC's EDGAR database and on financial research platforms like MarketBeat. Companies are required by law to make these disclosures accessible to all investors — meaning retail investors have access to the same source documents as institutional analysts.

A 10-K is an annual report containing audited financial statements and a full review of the company's business — it is the most comprehensive filing a company makes each year. A 10-Q is a shorter, unaudited quarterly update filed three times per year between annual reports. Investors typically use the 10-K for deep fundamental analysis and the 10-Q to track whether the company is on pace with its guidance mid-year.

The most important filing for fundamental investors. Filed once per year, the 10-K contains audited financial statements, revenue and earnings trends, debt obligations, risk factors, and management's own assessment of the business. Reading the risk factors section and comparing year-over-year financials can reveal issues that don't show up in analyst summaries.

An unaudited financial update filed three times per year (the 10-K covers Q4). Investors use 10-Qs to track whether guidance is on pace, monitor changes in cash flow or inventory, and catch any mid-year shifts in business conditions before they become headline news.

Filed within four business days of a material event — earnings releases, merger announcements, executive departures, or major asset sales. Because 8-Ks are filed before media coverage catches up, they are often the fastest way to get unfiltered information directly from the company on market-moving events.

Filed within two business days whenever an executive or director buys or sells company stock. Insider purchases — especially large or clustered buys — are often interpreted as a signal of management confidence. Insider selling is more ambiguous but worth monitoring for patterns, particularly around lock-up expirations or ahead of major announcements.


Related Companies and Tools


This page (NASDAQ:NIVF) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners